HOME >> BIOLOGY >> NEWS
Even the Immune System works with Pincers

Max-Planck-Scientists decipher central protein complex in the human immune system / Relevance for future therapies in allergies, autoimmune diseases and transplantation medicine

A key building block of the human immune system was identified up to the atomic detail using the method of x-ray crystallography by scientists of the Max-Planck-Institute for Biochemistry in Martinsried/Germany (Nature, 20. July 2000, S. 267-273). The protein complex, a mediator between the soluble and cellular compounds of the immune components in the blood, consists of an antibody and its respective receptor. Their dialogue in the immune system ensures that pathogenic germs which were previously labeled with antibodies are removed by receptor-equipped immune cells, eg macrophages. The identification of the structure and of the exact location of the interaction site between both proteins opens new possibilities not only for the therapy of diseases like allergies or autoimmune diseases, but also in the field of transplantation medicine.

The most important weapon in the defense of diseases in the human organism are Y-shaped antibodies, the so-called immunoglobulins (Ig). Many quintillions of antibodies with more than a trillion different specificities are found in the blood of the human body. These subdivide themselves - as within all mammals - into five different antibody types: IgM, IgG, IgA, IgD and IgE. Every class has its own particular characteristics that makes it possible to adopt a certain defense function. IgA for example, can be transported through the uppermost layer of the skin and is found in saliva, sweat and tears.

The well investigated immunoglobulin IgG is, with 80 percent, the most abundant antibody class in the circulation. It easily passes through walls of blood vessels or the placental barrier and confers, by this, passive immun
'"/>

Contact: Peter Sondermann
sonderma@biochem.mpg.de
49-89-85782701
Max-Planck-Gesellschaft
27-Jul-2000


Page: 1 2 3

Related biology news :

1. Immune systems attack dogs kept on genetic leash
2. Immune system drug may increase availability of liver transplants
3. Immune cells may help deliver cancer vaccines for children
4. Immune response depends on key molecule: Research
5. Applied Biosystems and Immune Tolerance Network announce immunology research agreement
6. Immune system component found common to both humans and worms
7. Immune cells SLAP internal signals together
8. Immune co-stimulation and the Kaposis virus
9. Immune system helps prevent tumors after all
10. Immune system chemical may predict worsening of coronary heart disease in women
11. UWs new Cell Systems Initiative welcomes Immunex collaboration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
(Date:1/6/2017)... Colo. , Jan. 5, 2017  SomaLogic ... the "Digital Life Alliance" established by iCarbonX, the ... 2015 to build a "Global Digital Health Ecosystem ... on a combination of individual,s biological, behavioral and ... the agreement between the companies, SomaLogic will provide ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Research and Markets ... has announced the addition of the "Implantable Biomaterials ... report to their offering. Report Highlights: ... detailed analysis on current and future market trends to identify the investment ... as the base numbers Key market trends across the ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics ... its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing ... existing policy. AMIA recommended that NIH earmark funding for researchers to produce and ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita ... full spectrum of drug and device development, and Prism Clinical Research , ... clinicians, today announced Verified Clinical Trials (VCT) has been selected by ...
Breaking Biology Technology:
Cached News: